Dr. Martens (LON:DOCS) Sets New 52-Week High - Here's What Happened

Key Points

• Dr. Martens' share price recently reached a new 52-week high of **GBX 96.50** ($1.31), closing at **GBX 91.80** ($1.24) with a volume of over **2.2 million shares traded**.
• Analysts are divided on the stock, with **one "buy" rating** and **two "holds"**, while the average consensus price target stands at **GBX 6,000**.
• Insider **Giles Wilson** purchased **105,838 shares** at **GBX 91** per share, contributing to a total insider buy of **136,633 shares** valued at around **$12.4 million** in the last quarter.

Dr. Martens plc (LON:DOCS - Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 96.50 ($1.30) and last traded at GBX 91.80 ($1.24), with a volume of 2227395 shares. The stock had previously closed at GBX 92 ($1.24).

Analyst Ratings Changes

Several equities research analysts have issued reports on DOCS shares. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Dr. Martens in a research note on Friday, July 11th. Peel Hunt raised shares of Dr. Martens to a "buy" rating in a research note on Monday, August 18th. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of GBX 6,000.

Dr. Martens Stock Performance

The firm's 50-day moving average price is GBX 84.44 and its two-hundred day moving average price is GBX 68.86. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The stock has a market cap of £872.00 million, a price-to-earnings ratio of 18,060.00, a PEG ratio of 6.40 and a beta of 0.11.

Insider Buying and Selling at Dr. Martens

In other news, insider Giles Wilson purchased 105,838 shares of the stock in a transaction dated Monday, September 1st. The shares were purchased at an average price of GBX 91 per share, with a total value of £96,312.58. Over the last 90 days, insiders have bought 136,800 shares of company stock worth $12,437,769. Insiders own 2.76% of the company's stock.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.